rs776443981
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_001042432.2(CLN3):c.1225A>G(p.Met409Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,613,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001042432.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLN3 | NM_001042432.2 | c.1225A>G | p.Met409Val | missense_variant | Exon 16 of 16 | ENST00000636147.2 | NP_001035897.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLN3 | ENST00000636147.2 | c.1225A>G | p.Met409Val | missense_variant | Exon 16 of 16 | 1 | NM_001042432.2 | ENSP00000490105.1 | ||
ENSG00000261832 | ENST00000637378.1 | c.228+4497A>G | intron_variant | Intron 4 of 9 | 5 | ENSP00000490831.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151996Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250566Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135508
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461752Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727168
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151996Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74236
ClinVar
Submissions by phenotype
not provided Uncertain:1
p.Met409Val (ATG>GTG): c.1225 A>G in exon 16 of the CLN3 gene (NM_001042432.1). The Met409Val missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The Met409Val variant alters a well conserved region across species in the cytoplasmic C-terminus region of the CLN3 protein and a nearby missense mutation has been reported in this region of the CLN3 protein in association with neuronal ceroid lipofuscinosis (Kousi et al., 2012). In addition, in silico analysis predicts this variant is probably damaging to the protein structure/function. However, this variant is a conservative substitution of one uncharged non-polar amino acid for another. Therefore, based on the currently available information, it is unclear whether Met409Val is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). -
Neuronal ceroid lipofuscinosis Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 409 of the CLN3 protein (p.Met409Val). This variant is present in population databases (rs776443981, gnomAD 0.01%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 33507216). ClinVar contains an entry for this variant (Variation ID: 205101). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Neuronal ceroid lipofuscinosis 3 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at